Dr. Jacono is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8500Fax+1 216-421-3217
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1998 - 2001
- Washington University in St. Louis School of MedicineClass of 1998
Certifications & Licensure
- OH State Medical License 2004 - 2026
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Persistent glossopharyngeal nerve respiratory discharge patterns after ponto-medullary transection.Gijnovefa Kola, Eriko Hamada, Rishi R Dhingra, Frank J Jacono, Thomas E Dick
Respiratory Physiology & Neurobiology. 2024-09-01 - 2 citationsPeritoneal sepsis caused by Escherichia coli triggers brainstem inflammation and alters the function of sympatho-respiratory control circuits.Gjinovefa Kola, Caitlyn W Clifford, Cara K Campanaro, Rishi R Dhingra, Mathias Dutschmann
Journal of Neuroinflammation. 2024-02-08 - Keeping Cardiac Arrest Documentation Alive in the Electronic Medical Record.Pallavi Sharma, Gavriella Pora, Paarth Sharma, Frank J Jacono, Maroun Matta
ATS Scholar. 2023-12-01
Press Mentions
- Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3 Trial Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDSMay 5th, 2020
- Athersys and University Hospitals Cleveland Medical Center Announce Activation of the First Clinical Site for the MACOVIA Study, a Pivotal Phase 2/3 Study Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDSMay 1st, 2020
- UH Cleveland Medical Center Will Be the First Clinical Site for a New Athersys Inc. TrialMay 1st, 2020
- Join now to see all
Grant Support
- Neuroinflammation disrupts cardio-respiratory circuits and patternsLOUIS STOKES CLEVELAND VA MEDICAL CENTER2024–2028
- Neuroinflammation Maladapts Cardio Respiratory Circuits and PatternsCASE WESTERN RESERVE UNIVERSITY2022–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: